Thank you to the attendees, faculty, sponsors, and supporters of the SDEF's Annual Las Vegas Dermatology Seminar & the Annual Psoriasis and Atopic Dermatology Forums for making the conference a tremendous success! We hope to see you again in 2020. SIGN UP for email updates to keep informed of program developments for our upcoming conference as they become available.
Exhibitor/Sponsor Profiles 2019
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. www.amgen.com
Bio-Oil® is a specialist skincare product that helps improve the appearance of scars, stretch marks, and uneven skin tone. Its advanced formulation, which contains the breakthrough ingredient PurCellin Oil™, also makes it highly effective for numerous other skin concerns including aging and dehydrated skin. Learn more www.bio-oil.com
Cassiopea, Inc. is a clinical-stage pharmaceutical company developing and commercializing innovative medical dermatology products, including a pipeline of topical androgen receptor inhibitor products, using a new chemical entity called clascoterone.
Our commitment to Dermatology is built around a senior leadership team with deep roots and experience in the specialty. The management team is focused on providing unique treatment options, and to drive continued research and development in Dermatology, moving us to the forefront of the U.S. market.
Castle Biosciences is a provider of molecular diagnostics to improve cancer treatment decisions. DecisionDx®-Melanoma uses tumor biology to provide an individual risk of melanoma recurrence beyond traditional factor such as AJCC staging criteria and sentinel lymph node status. DecisionDx®-UM enables accurate staging of five-year metastatic risk in uveal melanoma and is standard of care in a majority of ocular oncology practices. Castle Biosciences is based in Friendswood TX and has laboratory operations in Phoenix AZ (www.castlebiosciences.com).
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next‐generation solutions in protein homeostasis, immuno‐oncology, epigenetics, immunology and neuro‐inflammation.
Dermavant Sciences is a biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. www.dermavant.com
Foamix is a specialty pharmaceutical company, committed to addressing unmet needs and providing new options for patients by bringing innovative solutions to the field of dermatology. With our expertise in topical medicine innovation as a springboard, we’re working to develop and commercialize solutions that were long thought impossible.©
Janssen Biotech, Inc., a member of Janssen Pharmaceutical Companies of Johnson & Johnson, delivers on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a legacy of innovative firsts, Janssen Biotech pursues advancing patient care with immunology and oncology solutions. www.janssen.com
Legally Mine is an asset protection and tax strategy group. The mission of Legally Mine is to empower members of the healthcare and business communities with the knowledge and tools to protect their assets from lawsuits, build professional license safeguards into their legal structures and legitimately reduce their tax liability.
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
Mallinckrodt Pharmaceuticals is a global specialty pharmaceutical company. The company’s Autoimmune and Rare Diseases business includes H.P. Acthar® Gel (repository corticotropin injection), indicated for use in multiple specialties. To learn more, visit www.Acthar.com
Novartis Pharmaceuticals is dedicated to discovering, developing, manufacturing, and marketing prescription drugs that help meet our customers’ medical needs and improve their quality of life. Visit the Novartis exhibit where our representatives are available to discuss our products. www.novartis.com
Ortho Dermatologics is committed to the dermatology community and healthcare providers, by helping treat patients in therapeutic areas including acne, immunology and psoriasis. Learn more at www.ortho-dermatologics.com.
Pfizer is one of the world’s premier innovative biopharmaceutical companies, which brings therapies to patients that significantly improve their lives. These include medicines and vaccines along with many of the world’s best-known consumer healthcare products. www.pfizer.com
Ra Medical Systems, Inc., markets the Pharos Optimized, an advanced 308-nm UVB excimer laser for psoriasis, vitiligo, atopic dermatitis, and leukoderma. It is fast, safe, and powerful for difficult-to-treat psoriasis including scalp, palms and soles, and intertriginous lesions and for localized vitiligo, including facial and peri-orbital areas. ramed.com
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Our medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on development and commercialization of novel oncology therapeutics. ELZONRIS (tagraxofusp), a targeted therapy directed to CD123, is FDA-approved and available in the US for treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN). In Europe, a marketing authorization application (MAA) is under review. stemline.com
SPII is a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd, a global specialty generic company based in Mumbai, which provides innovative, high-quality, affordable medicines trusted by customers and patients in over 150 countries around the world. It fosters excellence through innovation, supported by strong R&D capabilities, with approximately 2,000 scientists on staff and R&D investments of approximately 8% of annual revenues. It has been marketing its products in the US market for more than 20 years, providing generics, branded generics and over-the-counter products, and has distribution and customer service teams throughout the US. For further information please visit www.sunpharma.com and follow us on Twitter at @SunPharma_Live